Harpoon Therapeutics Inc logo

Harpoon Therapeutics Inc

$ 1.08 +0.05 (+4.85%) 04:00 PM EST
P/E:
At Loss
P/B:
2.12
Market Cap:
$ 35.89M
Enterprise V:
$ -20.90M
Volume:
404.12K
Avg Vol (2M):
3.30M
Also Trade In:
Volume:
404.12K
Market Cap $:
35.89M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.30M
Enterprise Value $:
-20.90M
PB Ratio:
2.12

Business Description

Description
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 6.02
Equity-to-Asset 0.2
Debt-to-Equity 0.65
Debt-to-EBITDA -0.16
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.49
Distress
Grey
Safe
Beneish M-Score -1.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.55
9-Day RSI 61.32
14-Day RSI 59.89
6-1 Month Momentum % -62.78
12-1 Month Momentum % -85.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.28
Quick Ratio 1.28
Cash Ratio 1.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.1